PubRank

Michael I Nishimura

Author PubWeight™ 55.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother 2008 6.55
2 Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 2010 3.15
3 Cancer classification using the Immunoscore: a worldwide task force. J Transl Med 2012 2.88
4 Recognition of host immune activation by Pseudomonas aeruginosa. Science 2005 2.84
5 Defining the critical hurdles in cancer immunotherapy. J Transl Med 2011 2.32
6 Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity 2002 2.18
7 Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med 2013 1.66
8 Cutting edge: identification of hepatitis C virus-specific CD8+ T cells restricted by donor HLA alleles following liver transplantation. J Immunol 2004 1.54
9 CD4 and CD8 T-lymphocyte recognition of prostate specific antigen in granulomatous prostatitis. J Immunother 2004 1.54
10 Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor. Cancer Res 2005 1.44
11 CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell. J Immunol 2003 1.38
12 Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses. Proc Natl Acad Sci U S A 2010 1.36
13 Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidity. J Immunol 2003 1.32
14 Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor. Nat Immunol 2007 1.22
15 Therapeutic implications of autoimmune vitiligo T cells. Autoimmun Rev 2006 1.12
16 Adoptive transfer of allogeneic cytotoxic T lymphocytes equipped with a HLA-A2 restricted MART-1 T-cell receptor: a phase I trial in metastatic melanoma. Clin Cancer Res 2006 1.09
17 Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells. J Immunol 2003 1.09
18 Reduced skin homing by functional Treg in vitiligo. Pigment Cell Melanoma Res 2010 1.09
19 T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2. Int J Cancer 2010 1.03
20 Inhibition of superoxide generation upon T-cell receptor engagement rescues Mart-1(27-35)-reactive T cells from activation-induced cell death. Cancer Res 2009 1.03
21 Human antigen-specific regulatory T cells generated by T cell receptor gene transfer. PLoS One 2010 1.03
22 Transduction with the antioxidant enzyme catalase protects human T cells against oxidative stress. J Immunol 2008 0.98
23 Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity. PLoS Pathog 2010 0.96
24 Cervical cancer vaccines: recent advances in HPV research. Viral Immunol 2003 0.95
25 A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice. J Immunol 2012 0.94
26 T cell avidity and tumor recognition: implications and therapeutic strategies. J Transl Med 2005 0.93
27 T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cells. Cancer Immunol Immunother 2005 0.91
28 CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting. Cancer Immunol Immunother 2010 0.90
29 Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells. Cancer Res 2006 0.89
30 Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition. Hepatology 2006 0.89
31 Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells. Am J Pathol 2009 0.88
32 CD8 co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-β (TGF-β)-mediated suppression. Cancer Immunol Immunother 2010 0.83
33 Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination. Cancer Immunol Immunother 2008 0.83
34 T cell immunotherapy. Front Biosci 2007 0.82
35 Interferon-gamma renders tumors that express low levels of Her-2/neu sensitive to cytotoxic T cells. Cancer Immunol Immunother 2005 0.81
36 Redirecting T lymphocyte specificity using T cell receptor genes. Int Rev Immunol 2003 0.80
37 Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition. Cancer Immunol Immunother 2008 0.79
38 Adoptive immunotherapy of cancer: Gene transfer of T cell specificity. Self Nonself 2011 0.78
39 Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. Pigment Cell Melanoma Res 2014 0.78
40 Retroviral transduction of peptide stimulated t cells can generate dual t cell receptor-expressing (bifunctional) t cells reactive with two defined antigens. J Transl Med 2004 0.77
41 Regulatory balance between the immune response of tumor antigen-specific T-cell receptor gene-transduced CD8 T cells and the suppressive effects of tolerogenic dendritic cells. Cancer Sci 2005 0.77
42 Structure-activity relationship of T-cell receptors based on alanine scanning. Biochem Biophys Res Commun 2011 0.76
43 Retroviral transfer of T-cell receptor genes into human peripheral blood lymphocytes. Methods Mol Biol 2003 0.75
44 A new murine tumor model for studying HLA-A2-restricted anti-tumor immunity. Cancer Lett 2004 0.75